Skip to main content
. Author manuscript; available in PMC: 2019 Feb 27.
Published in final edited form as: J Allergy Clin Immunol. 2018 Jan 17;142(2):497–509.e9. doi: 10.1016/j.jaci.2017.09.052

Fig E5.

Fig E5

Comparison of asthma scores in treatment groups. Shown are mean asthma scores with 95% CIs (y-axes) during the peak pollen seasons of treatment years 1 (placebo, BM32 low-dose, and BM32 high-dose groups) and 2 (placebo, BM32 pooled, BM32 low-low, and BM32 high-low groups) for the FAS population. P values for comparisons of the placebo group with treatment groups are indicated.